Interferon -1b–neutralizing antibodies 5 years after clinically isolated syndrome

Hp Hartung,Mark S Freedman,Chris Polman,G. Edan,Ludwig Kappos,David H. Miller,Xavier Montalban,Frederik Barkhof,J. Petkau,R. White,Vivek Sahajpal,V. Knappertz,Karola Beckmann,Vivian Lanius,Rupert Sandbrink, Corina Pohl

Neurology（2020）

引用 36|浏览4

暂无评分

摘要

Although NAb positivity was associated with increased brain MRI activity, no discernible effects on clinical outcomes were found. This finding may reflect the greater power of MRI compared with clinical outcomes to detect the treatment effects of IFNβ-1b and may also result from temporal changes in NAb titers and biology.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要